| # | Drug | Count |
|---|---|---|
| 0 | MYCOPHENOLATE MOFETIL | 29 |
| 1 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 29 |
| 2 | TACROLIMUS | 20 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 20 |
| 4 | TACROLIMUS OINTMENT 0.1% | 20 |
| 5 | ETANERCEPT | 19 |
| 6 | ALEMTUZUMAB | 17 |
| 7 | ANAKINRA | 17 |
| 8 | SIROLIMUS | 16 |
| 9 | METHOTREXATE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | 3% SODIUM CHLORIDE | 1 | 0.0088 |
| 1 | BENZETHONIUM CHLORIDE | 1 | 0.0078 |
| 2 | UNDECYLENIC ACID | 1 | 0.0072 |
| 3 | TOLNAFTATE 1% | 1 | 0.0034 |
| 4 | BENZALKONIUM CHLORIDE 0.13% | 1 | 0.0027 |
| 5 | BENZALKONIUM CHLORIDE | 1 | 0.0023 |
| 6 | CERLIPONASE ALFA | 1 | 0.0019 |
| 7 | SODIUM THIOSULFATE | 1 | 0.0018 |
| 8 | SILTUXIMAB | 1 | 0.0015 |
| 9 | SULINDAC | 3 | 0.0012 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Interleukin-1 Receptor Antagonist [EPC] | 17 | 0.0010 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 17 | 0.0009 |
| 3 | Cannabinoid [EPC] | 3 | 0.0004 |
| 4 | Antiseptic [EPC] | 1 | 0.0002 |
| 5 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 6 | CTLA-4-directed Blocking Antibody [EPC] | 7 | 0.0001 |
| 7 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 8 | Antimetabolite Immunosuppressant [EPC] | 2 | 0.0001 |
| 9 | Glycopeptide Antibacterial [EPC] | 6 | 0.0001 |